ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tackle tough lung cancer
Disease control Recruiting nowThis phase 2 trial is testing two experimental drugs, ubamatamab and REGN7075, alone or together, in 300 people with advanced or metastatic non-small cell lung cancer who have already had standard treatments. A third drug, sarilumab, may be used to manage immune-related side effe…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Pfizer launches early trial of PF-08634404 combo for tough lung cancers
Disease control Recruiting nowThis study tests a new experimental drug called PF-08634404 combined with other cancer medicines in people with advanced non-small cell lung cancer that has spread and can't be surgically removed. The trial has two parts: one combining PF-08634404 with sigvotatug vedotin, and ano…
Matched conditions: ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC